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Development of Timd2 as a Reporter Gene for MRI
P. Stephen Patrick,1,2 Tiago B. Rodrigues,2 Mikko I. Kettunen,2 Scott K. Lyons,2
Andre A. Neves,2 and Kevin M. Brindle1,2*
Purpose: To assess the potential of an MRI gene reporter
based on the ferritin receptor Timd2 (T-cell immunoglobulin
and mucin domain containing protein 2), using T1- and T2-
weighted imaging.
Methods: Pellets of cells that had been modified to express
the Timd2 transgene, and incubated with either iron-loaded or
manganese-loaded ferritin, were imaged using T1- and T2-
weighted MRI. Mice were also implanted subcutaneously with
Timd2-expressing cells and the resulting xenograft tissue
imaged following intravenous injection of ferritin using T2-
weighted imaging.
Results: Timd2-expressing cells, but not control cells, showed
a large increase in both R2 and R1 in vitro following incubation
with iron-loaded and manganese-loaded ferritin, respectively.
Expression of Timd2 had no effect on cell viability or prolifera-
tion; however, manganese-loaded ferritin, but not iron-loaded
ferritin, was toxic to Timd2-expressing cells. Timd2-expressing
xenografts in vivo showed much smaller changes in R2 follow-
ing injection of iron-loaded ferritin than the same cells incu-
bated in vitro with iron-loaded ferritin.
Conclusion: Timd2 has demonstrated potential as an MRI
reporter gene, producing large increases in R2 and R1 with ferri-
tin and manganese-loaded ferritin respectively in vitro, although
more modest changes in R2 in vivo. Manganese-loaded apo-
ferritin was not used in vivo due to the toxicity observed in
vitro. Magn Reson Med 000:000–000, 2015. VC 2015 The
Authors. Magnetic Resonance in Medicine published by
Wiley Periodicals, Inc. on behalf of International Society
for Magnetic Resonance in Medicine. This is an open
access article under the terms of the Creative Commons
Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is
properly cited.
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INTRODUCTION
A variety of MR reporter genes have been developed that
are detectable in T2- and T1-weighted
1H images (1–17),
in 19F images and spectra (18–20) and in 31P spectra
(20–24). Recent work has also investigated the potential
of MR gene reporter systems that use hyperpolarized
13C-labeled metabolites (25–27) and 129Xe-based probes
(28), although of these only one has been demonstrated
in vivo (27). Chemical exchange saturation transfer
(CEST) is another promising method for producing MR
contrast for which gene reporters have been developed
(29–31). The signal can be switched on and off and,
because contrast agents can have exchangeable protons
at different frequencies, there is the possibility of
“multicolor” imaging. However, the sensitivity of detec-
tion in these systems has so far been relatively low.
Various MR reporter systems have also been devised
that incorporate multimodal imaging, including LacZ
(11,14,18–20,32), tyrosinase (7,13,33–35), mbGlucBiotin
(10), and BAP-TM (9). Two of the more promising multi-
modal approaches use DMT1, which is a transporter for
manganese (15), and Oatp1, which transports a clinically
approved gadolinium-based contrast agent (16). These
produce higher levels of contrast in T1-weighted images
than reporters described previously, as well as function-
ing as radionuclide imaging reporters (16,36) and, in the
case of Oatp1, enhancing bioluminescence signal from
luciferase-expressing cells as well (37).
Ferritin, a polymeric spherical iron storage protein,
has been one of the more widely used reporters
(1–3,5,38). Accumulation of ferritin above normal back-
ground levels can be detected as a hypointense signal in
T2-weighted images, allowing ferritin transgene expres-
sion to be detected. However, the change in relaxivity
that can be achieved by ferritin overexpression is often
small due to limited iron availability and accumulation,
and therefore the change in image contrast can be diffi-
cult to detect (3). One approach to improving sensitivity
has been to increase iron uptake by overexpression of
the transferrin receptor (4). While this increased the abil-
ity of cells to take up transferrin in vitro, the improve-
ment in image contrast in vivo was still quite modest.
We have investigated here exploitation of another iron
uptake mechanism as an MRI-based gene reporter: the
receptor Timd2 (T-cell immunoglobulin and mucin
domain containing protein 2) that mediates ferritin endo-
cytosis (39–41). T-cell immunoglobulin and mucin
domain containing protein 2 (Timd2; also known as
TIM-2) is a murine protein that is expressed primarily
on immune cells, where it plays a role in signaling.
Timd2 expression elsewhere is limited, but is also found
in both liver and kidney, where it functions primarily as
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a ferritin receptor to remove ferritin from the blood (40),
as well as on oligodendrocytes, where it is upregulated
during myelination to meet increased iron demands (39).
Because ferritin can hold up to 4000 iron atoms in its
internal cavity, compared with two atoms in transferrrin,
this reporter offers a potentially more sensitive alterna-
tive to the transferrin receptor-based reporter. In addi-
tion, the iron in ferritin can be exchanged for manganese
(42), making it an effective T1 contrast agent (43), as well
as a T2 contrast agent.
We demonstrate in vitro that cells expressing Timd2
and incubated with ferritin or manganese-loaded apofer-
ritin showed large increases in R2 and R1, respectively.
Cells expressing Timd2 implanted as xenografts in mice
also showed changes in R2 following intravenous injec-
tion of ferritin, although these changes in contrast were
more modest than those observed in vitro. Due to the
observed toxicity with manganese-loaded apoferritin in
vitro this agent was not pursued further in vivo. Timd2
represents another addition to the growing number of
proteins that can be used as MRI-based gene reporters.
METHODS
Cell Culture
All experiments were carried out using HEK 293T (human
embryonic kidney) cells. Cells were cultured in 5% CO2,
at 37C, in Dulbecco’s modified Eagle’s medium (DMEM,
Life Technologies), supplemented with 10% fetal bovine
serum and 2 mM L-glutamine (Life Technologies).
Production of the Lentiviral Transfer Plasmid
A sequence encoding mStrawberry (44), E2A (amino acids
QCTNYALLKLAGDVESNPGP) (45), and murine Timd2
(NCBI reference sequence NM_001161356.1), was initially
assembled in a pBluescript II plasmid. The three coding
sequences were arranged in frame, and the stop codon at
the end of mStrawberry was mutated so that only a single
stop codon at the end of Timd2 remained. The transgene
was then cloned into the lentiviral transfer vector back-
bone plasmid pBOBI (46) (a gift from Inder Verma, Salk
Institute, California). A 500 bp shortened mouse phospho-
glycerate kinase (PGK) promoter was inserted upstream of
this sequence. This promoter is constitutively active in
mammalian cells and is homologous to the human pro-
moter (47). The vector was sequenced to confirm that no
errors had been introduced during its construction.
Lentiviral Preparation
Replication defective vesicular stomatitis virus glycopro-
tein (VSV-G) pseudotyped lentiviral vectors were produced
(48), and purified (49) according to published protocols,
using the assembled pBOBI-PGK-mStrawberry-E2A-Timd2
transfer plasmid and three packaging plasmids. The pack-
aging plasmids, pMDL, pVSV-G, and pRSV-REV, were a
gift from Inder Verma (Salk Institute, California).
Fluorescent Labeling of Ferritin
Ten mg of horse spleen ferritin (Sigma-Aldrich) were dis-
solved in sodium borate buffer (100 mM, pH 9), at a con-
centration of 0.044 mg/mL and reacted with fluorescein
isothiocyanate (FITC, previously dissolved in dimethyl
sulfoxide at 13 mg/mL) for 1 h in the dark, at room tempera-
ture, while stirring at 100 rpm. The reaction was quenched
by the addition of a 500-fold molar excess of Tris-HCl (12
mM; pH 8). Unreacted FITC was removed by extensive
buffer-exchange into HBS buffer (HEPES-buffered saline:
20 mM HEPES, 150 mM NaCl, pH 7.4) using 30 kDa cut-off
spin filters (GE Healthcare). FITC-labeled ferritin was ana-
lyzed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE), with brightfield and fluorescence
detection to confirm successful labeling.
Confocal Microscopy
Cells were grown on sterile glass cover slips. Before
imaging the growth medium was removed and the cover
slips washed in phosphate-buffered saline (PBS) and
then inverted onto a glass slide with a drop of ProlongVR
Gold mounting medium containing DAPI (40,6-diami-
dino-2-phenylindole) nuclear stain (Life Technologies),
and left to dry in the dark. Slides were imaged using a
Leica Tandem confocal microscope with an oil objective.
Images were assembled as maximum projections from Z-
stacks of slices taken at 1-mm intervals.
Western Blot
Cells were lysed in 5 mL of cell lysis buffer (M-Per,
Thermo Scientific) per mg of cells, according to the man-
ufacturer’s instructions. Protein concentration was esti-
mated using the Bradford assay. Twenty mg of whole cell
lysate were mixed with 4 loading buffer (NuPAGE LDS
sample buffer, Life Technologies,) and 10 reduction
buffer (NuPAGE sample reducing agent, Life Technolo-
gies), made up to 20 mL with PBS, and heated to 70C for
10 min. Samples were run on a 4 to 12% PAGE gel
(NuPAGE Novex Bis-Tris gel 1 mm 10 well, Life Tech-
nologies), with a protein standard ladder (Kaleidoscope
Precision Plus Protein Standards, Bio-Rad), at 150 V for
75 min. Proteins were then blotted onto a nitrocellulose
membrane at 30 V for 60 min using TGS RunBlue trans-
fer buffer. For a-tubulin staining (loading control), mono-
clonal mouse anti-a-tubulin (T1568, Sigma-Aldrich) was
used at 1 in 1000 dilution with overnight incubation at
4C. For ferritin staining, polyclonal rabbit anti-ferritin
light-chain antibody (ab69090, Abcam) was used at 1 in
500 dilution with overnight incubation at 4C. For sec-
ondary antibody staining, horseradish peroxidase conju-
gated anti-rabbit and anti-mouse antibodies were used at
1 in 10,000 dilution with an incubation time of 45 min
at room temperature. All antibodies were diluted in Tris-
buffered saline (TBS), pH 7.6,þ 0.1% tween and 5%
milk powder. Membranes were washed 5 times before
and after all antibody incubations in TBSþ 0.1% tween.
For imaging, membranes were incubated in SuperSignal
Chemiluminescent substrate for 5 min, then exposed to
CL-XPosure film (both from Thermo-Scientific).
Preparation of Manganese-Loaded Apoferritin
Manganese-loaded apoferritin was prepared according to
(42). Briefly, horse spleen apoferritin was dissolved at a
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concentration of 3 mM in 5 mL AMPSO (N-(1,1-
Dimethyl-2-hydroxyethyl)-3-amino-2-hydroxypropanesul-
fonic acid) buffer (0.05 M, pH 8.9). To this was added
MnCl2 to a concentration of 9 mM (3000 manganese
ions per apoferritin). The solution was left overnight, so
that any large insoluble MnOOH particles not formed in
the ferritin cavity would sediment, and was then buffer
exchanged into HEPES-buffered saline (pH 7.4) using a
Vivaspin centrifugation filter (GE Healthcare) with
molecular cut-off weight of 30 kDa. Protein concentration
was estimated using the Bradford Assay.
Flow Cytometry
A polyclonal population of cells transduced with the
mStrawberry-Timd2 lentivirus, and untransduced cells,
were incubated with various concentrations of FITC-
labeled ferritin at 37C, washed with PBS, trypsinized,
and suspended in PBS. One thousand events were
recorded per population. Forward and side scatter were
measured to estimate cell viability. Fluorescence at
530 nm was used to detect the presence of FITC-ferritin.
Transgenic cells were identified by increased fluores-
cence at 630 nm, indicating expression of mStrawberry.
Flow cytometry data were acquired using a FACSCalibur
flow cytometer (BD Biosciences), and analyzed using
FlowJo software (Treestar).
Preparation of Cell Pellets for MRI
A polyclonal population of HEK 293T cells transduced
with the mStrawberry-Timd2 lentivirus (multiplicity of
infection of 2), or untransduced cells, were grown on
15 cm plates (Nunc), until they were 80% confluent.
These were incubated for different lengths of time, at
which their relaxivities were measured following incuba-
tion with either 75 nM horse spleen ferritin or 75 nM
manganese-loaded apoferritin. After incubation, cells
were gently washed with PBS, trypsinized with 0.25%
trypsin (Life Technologies), and resuspended in PBS.
The cells were pelleted in Eppendorf tubes using a
microcentrifuge and kept on ice before imaging.
MRI
Experiments were carried out in a 7 Tesla (T) horizontal
magnet (Oxford Instruments, UK) interfaced to a VNMRS
(Varian Inc) imaging console. A 72-mm-diameter quadra-
ture volume coil (Rapid Biomedical) was used in trans-
mit/receive mode. A 2-mm imaging slice was selected
through the sample tubes or mice (field of view 80 
80 mm). Longitudinal (T1) relaxation times were meas-
ured using an inversion recovery-FLASH sequence (data
matrix 128  64, repetition time 5 ms, echo time 3 ms,
26-s delay between inversions, 9 inversion times between
0.1 and 25.6 s, two acquisitions per inversion time).
Transverse (T2) relaxation times were measured using a
multiecho sequence (data matrix 256  128, repetition
time 2 s, echo spacing 10 ms, 64 echoes). Imaging data
were fitted to exponentials using Matlab software (Math-
works). During imaging mice were kept under anesthesia
using 2% Isofluorane in oxygen, and breathing rate was
monitored. Body temperature was monitored using a rec-
tal probe, and maintained using heated air.
Iron Assay
Cellular iron content was assayed using a published pro-
tocol (50).
Electron Microscopy
Cells were grown to 80% confluence, washed twice
with 0.9% saline, fixed for 2 h on ice in a mixture of
2.5% glutaraldehyde and 2% formaldehyde, and scraped
into Eppendorf tubes and pelleted. Fixed cells were
rinsed 3 times in 0.1 M PIPES buffer and osmicated by
incubating for 1 h in 1% osmium tetroxide with 1.5%
potassium ferricyanide. They were rinsed four times in
distilled water, bulk stained in 2% uranyl acetate in
0.05 M maleate buffer at pH 5.5, rinsed 3 times in dis-
tilled water and dehydrated with graded solutions of
ethanol (70%, 95%, and 100%) for 5 min in each solu-
tion. They were then incubated in 50% acetonitrile 50%
epoxy resin, without a catalyst. This was followed by
five daily changes of pure resin with no catalyst. Sam-
ples were then placed in coffin molds in degassed resin
and air was excluded by covering the resin with a thin
Aclar sheet (Agar Scientific) and cured at 60C for 24 h.
Fifty nanometer sections were cut and mounted on bare
300-mesh copper grids and viewed using a Philips
CM100 transmission electron microscope operated at 80
kV.
Toxicity Assay
To measure the effect of reporter gene expression and
uptake of ferritin and manganese-loaded ferritin on cell
growth, the proliferation rate of the cells was measured
over the space of a week. Cells expressing the transgene,
and untransduced cells, were seeded into wells of a six-
well plate (Nunc), and incubated in either growth media,
or growth media containing 75 nM ferritin or
manganese-loaded ferritin. Growth rate was determined
by measuring the percentage area of each well covered
by cells at 3-hourly intervals using an Incucyte system
(Essen Bioscience). Cells were allowed to grow for 24 h
before addition of the contrast agent, to control for cell
growth under normal conditions. Cell viability was
assessed using Trypan blue dye exclusion using an auto-
mated Vi-cell (Beckman-Coulter) counter, according to
the manufacturer’s instructions.
Animal Studies
Female mice with severe combined immunodeficiency
(SCID) were purchased from Charles River, UK. At the
time of cell implantation, animals were aged between 6
and 8 weeks and weighed between 20 and 22 g. Xeno-
grafts, which were obtained by implanting 1  107 HEK
293T cells suspended in 100 mL PBS in each flank, were
imaged at 14 days after cell implantation. Procedures
were carried out under the authority of project and per-
sonal licenses issued by the Home Office, UK, and were
approved by local Animal Welfare and Ethical Review
Bodies.
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RESULTS
Timd2 Expression Mediates Uptake of Ferritin
Previous studies have shown that ferritin is endocytosed
by Timd2-expressing cells and processed by means of
the endocytic pathway into an acidic perinuclear com-
partment within 30 min (40,41,51,52). To confirm this
mechanism of uptake HEK 293T cells, which had been
transduced with a lentiviral vector expressing mStraw-
berry and Timd2, were incubated with FITC-labeled fer-
ritin and ferritin uptake followed using flow cytometry
and confocal microscopy (Fig. 1). There were concentra-
tion- (Fig. 1a) and time-dependent (Fig. 1b) increases in
mean fluorescence intensity following incubation of cells
with FITC-labeled ferritin but no changes in fluorescence
in control cells not expressing the receptor.
The intensity of fluorescein fluorescence is strongly
pH dependent (53,54) and has been used to study pro-
tein trafficking through organelles (55) and the increas-
ingly acidic endocytic pathway (56–59). In cells
incubated with a fixed concentration of FITC-ferritin
(75 nM) there was an increase in fluorescence between 0
and 40 min of incubation, which then remained rela-
tively constant for the next 20 min, before decreasing
over the next 30 min and then steadily increasing again
thereafter (Fig. 1b). FITC is most fluorescent above pH 7,
decreasing to below 40% of its maximum level at pH 6,
20% at pH 5.5, and less than 10% at pH 4 (54). Previous
investigations have described the endocytosis of ferritin
as it goes through the endocytic pathway: first to the
early endosome (pH 6) (51), which it can reach in as
little as 2 min (40), then the late endosome (pH 5-6), and
finally to the lysosome (pH 5.5-4) (57,60), where the iron
core is broken down (61–63). Together with these previ-
ous studies, the results presented in Figure 1b suggest
that ferritin accumulates in an acidic compartment,
which causes a decrease in fluorescence after 60 min.
The subsequent increase in fluorescence is likely to be
due to recycling of Timd2 receptors to the plasma mem-
brane, initiating further uptake, and/or release of FITC-
labeled peptides from the acidic lysosome (60). Confocal
microscopy (Fig. 1c) showed that after 4 min ferritin
appeared bound to the plasma membrane and also in
several small endosome-like compartments, consistent
with previous reports of ferritin uptake to endosomes
within 2 min of incubation (60,64). After 30 min, ferritin
was seen only in punctate cytoplasmic structures, sug-
gesting that all the available Timd2 receptors on the
plasma membrane had been endocytosed. FITC fluores-
cence then decreased at 90 min, and appeared to be
FIG. 1. Uptake of labeled ferritin by Timd2-expressing cells. a: Fluorescence of Timd2-expressing cells and control cells after 3 hours of
incubation with the indicated concentrations of FITC-labeled ferritin. b: Fluorescence of Timd2-expressing cells and control cells incu-
bated for the indicated times with FITC-labeled ferritin at a concentration of 75 nM. Fluorescence of the cells in (a) and (b) was meas-
ured using flow cytometry, where the points represent the mean fluorescence of four independent populations of 10000 cells, with the
mean for each population representing the mean fluorescence of the total cell population. Error bars show the standard deviation of the
means for the different cell populations. Some error bars are obscured by the data points. c: Confocal microscopy images showing
Timd2-expressing cells following incubation with FITC-labeled ferritin for the indicated times in minutes and at 24 h.
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located around the nucleus, consistent with a peroxiso-
mal location and the results shown in Figure 1b. At later
times the fluorescence increased (Fig. 1c), as was
observed with the flow cytometric studies, suggesting
that the Timd2 receptors had been recycled and that fur-
ther ferritin endocytosis had occurred.
Timd2 Expression Is Detectable Using T2-Weighted
Imaging
Incubating cells with 75 nM ferritin resulted in an
increase in the levels of intracellular ferritin, as deter-
mined by western blotting (Fig. 2a) and a corresponding
increase in iron content, as determined by staining cells
with Perl’s Prussian blue (Fig. 2b), in Timd2-expressing
cells but not in control cells. Cell pellets imaged at 7T
showed an increase in R2 in Timd2-expressing cells but
not in control cells (Fig. 2c,d). There was a linear
increase in R2 for Timd2-expressing cells with time, over
a period of nearly 70 h (R2¼ 0.9465), while there was no
significant increase in control cells (P¼ 0.5; r2¼0.026)
(Fig. 2d). The relaxation enhancement in Timd2-
expressing cells peaked with a >seven-fold increase in R2
above baseline. The increase in R2 in Timd2-expressing
cells was associated with an increase in iron (Fig. 2e) and
ferritin contents (Fig. 2a). These data are consistent with
previous findings that R2 increases linearly with iron-
bound-ferritin concentration in solution (65).
Transmission electron micrographs of Timd2-
expressing cells that had been incubated under the
same conditions as used for the MRI experiments,
showed no aggregation of ferritin initially (Fig. 3a), but
after 4 h ferritin aggregates of up to 200 nm in diameter
could be seen (Figs. 3c,d). By 24 h aggregates over 0.5
mm in diameter had formed (Figs. 3e–h), which
appeared denser at 48 and 72 h. Ferritin aggregates
were also visible in cells stained with Perls’ Prussian
blue (Fig. 2b).
Timd2-Mediated Mn-Loaded Apoferritin Uptake Enhances
T1 and T2 Relaxation
Manganese is an effective T1 contrast agent due to the
paramagnetism of its five unpaired electrons and can
form solid MnOOH mineral cores in apoferritin (42).
Images of cell pellets obtained from cells that had been
incubated for 30 min with Mn-apoferritin showed that
signal was increased in T1-weighted images (Fig. 4a)
and decreased in T2-weighted images (Fig. 4b) in cells
expressing Tim2d but not in control cells. This corre-
sponded to a significant increase in R1 (P¼ 0.005) (Fig.
FIG. 2. a: Western blot showing increase in
ferritin light-chain content of Timd2-
expressing cells, but not in untransfected
control cells, following incubation with fer-
ritin (75 nM). Bands indicating the pres-
ence of ferritin in untransfected control
cells were detectable after longer exposure
times (not shown). b: Perls’ Prussian blue
staining of fixed Timd2-expressing cells
showing increasing iron content with length
of incubation with ferritin (75 nM). c: T2-
weighted images of pellets of Timd2-
expressing and control cells that had been
incubated for the indicated times with
75 nM ferritin (TR¼2000 ms; TE¼20 ms;
slice thickness¼2 mm). d: R2 of Timd2-
expressing and untransfected control cells
incubated for the indicated times with
75 nM ferritin. R2¼0.9465 for Timd2-
expressing cells and R2¼0.026 for control
cells. The baseline R2s before ferritin incu-
bation were 13.456 2.13 and 14.962.09
in Timd2-expressing and untransfected
control cells respectively (n¼4; 6SD). e:
Iron content in Timd2-expressing cells and
untransfected control cells after incubation
for the indicated times with 75 nM ferritin.
Cellular iron content is displayed as a per-
centage of the total iron content of the
added ferritin. Points represent the mean
of 3 independent replicates, error bars
show 6SD. The baseline iron content in
untransfected control cells and Timd2-
expressing cells was 0.516 0.05 and
0.426 0.05 pg Fe/cell, respectively. This
rose to 0.616 0.1 and 1.316 0.03 pg Fe/
cell at their respective peaks at 6 and 48
hours of incubation with ferritin.
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4c) and R2 (P¼ 0.0003) (Fig. 4d) in cells expressing
Timd2, while there was no change in control cells.
Effect of Timd2 Expression and Incubation with Ferritin on
Cell Growth and Viability
Expression of Timd2 had no effect on the growth of HEK
293T cells when compared with nontransduced control
cells (Fig. 5a) and incubation of these cells with 75 nM
ferritin produced a slight increase in their rate of prolif-
eration. In contrast, incubation of Timd2-expressing cells
with 75 nM Mn-apoferritin markedly inhibited their rate
of proliferation and decreased their viability (Fig. 5b),
whereas it had no significant effect on the growth or via-
bility of control cells.
Detection of Timd2-Expressing Cells In Vivo Using T2-
Weighted Imaging
Xenografts were produced by implanting untransfected
control cells and mStrawberry-Timd2-expressing HEK
293T cells subcutaneously in the contralateral flanks of
mice and imaged at 14 d after implantation. Expression
of Timd2 was confirmed by staining tissue sections
obtained post mortem with an anti-red fluorescent pro-
tein (RFP) antibody that recognizes mStrawberry (Fig.
6a). The coding sequences for mStrawberry and Timd2
in the viral vector were separated by an E2A sequence,
which ensures that they are coexpressed (45). Hematoxy-
lin and eosin (H&E) staining showed that the tissue
architecture and levels of necrosis were similar in the
FIG. 3. Representative transmission electron micrographs of Timd2-expressing cells. a: No incubation with ferritin. b: Following 30 min
incubation with 75 nM ferritin, arrow indicates endocytic vesicle containing ferritin. c: Four-hour incubation, arrow points to a lysosome
containing ferritin. d: Four-hour incubation. Image of arrowed structure in c at higher magnification. e: Twenty-four-hour incubation,
arrow shows large lysosome containing ferritin. f: Image of arrowed structure in (e) at higher magnification. g: Twenty-four-hour incuba-
tion, arrow points to a group of multivesicular bodies and lysosomes, surrounded by tubular endosome. h: Higher magnification image
of the arrowed structure in g. Ferritin can be seen in the cytoplasm, multivesicular bodies, lysosome, and tubular endosome. i: Forty-
eight-hour incubation, arrow points to a group of three ferritin-containing lysosomes. j: Image of arrowed structure in (i) at higher magni-
fication. Ferritin is more densely packed within the lysosome than at 24 h. k: Seventy-two-hour incubation. Electron dense accumula-
tions are also prominent in the mitochondria, see arrows. l: Higher magnification image of (k), showing three lysosomes containing
ferritin. Ferritin is also visible in the cytoplasm.
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control xenografts and in the xenografts expressing
Timd2, consistent with Timd2 expression having no
measurable effect on the growth and viability of these
cells in vitro (Fig. 5). The xenografts were imaged before
i.v. administration of 11.2 mg ferritin and then again at
24 and 48 h, using a T2-weighted imaging sequence. Rep-
resentative images are shown in Figure 6b. There was a
significant increase in R2 in Timd2-expressing tissue
after 24 h, although this had disappeared by 48 h.
DISCUSSION
We have shown that Timd2-expression facilitates the cel-
lular accumulation of ferritin and manganese-loaded
apoferritin, leading to large enhancements in R2 and R1
in vitro. The peak R2 enhancement observed here of
greater than seven-fold at 7T is better than or comparable
with enhancements measured previously in vitro in cells
expressing other T2-based reporter genes, including a
four-fold increase in R2 at 3T in 293FT cell pellets
expressing the MagA transgene (6), a two- to three-fold
increase at 7T in cells coexpressing the ferritin and
transferrin genes (4), and a two-fold increase in R2, pro-
duced by a chimeric re-engineered ferritin reporter with
improved iron loading, after 24 h of incubation with iron
(66). The increase in R2 observed here was much greater
than that expected from the amount of ferritin added to
FIG. 4. a: T1-weighted images of pellets of Timd2-expressing and control cells that had been incubated with 75 nM Mn-apoferritin for
30 min. (TR¼5 ms TE¼3 ms). b: T2-weighted images of cell pellets of Timd2-expressing and control cells that had been incubated
with 75 nM Mn-apoferritin for 30 min. (TR¼2 s TE¼30 ms). c: Changes in R1 in Timd2-expressing and control cells after 30 min of
incubation with 75 nM Mn-apoferritin. Points show the mean of at least 4 results, error bars show 6SEM. d: Changes in R2 in Timd2-
expressing and control cells after 30 min of incubation with 75 nM Mn-apoferritin. Points show the mean of at least 4 results, error bars
show 6SEM.
FIG. 5. Effect of Timd2 expression and incubation with ferritin or manganese-loaded ferritin on cell growth. Cell growth is expressed as
the percentage cell coverage of the well. a: After 30 h of cell growth Timd2-expressing and control cells were incubated with 75 nM
Mn-apoferritin, or ferritin, as indicated by the vertical dotted line. b: Effect of Timd2 expression and incubation with ferritin or
manganese-loaded ferritin on cell viability.
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the cells. Assuming an R2 of 1500 s
1mM1 for ferritin,
which was measured at 7T in HEPES buffered saline,
and that all the added ferritin was present in the cell
pellet, then the expected increase in R2 is 26 s
1 above a
background R2 of around 14 s
1, which means that the
peak R2 should be 40 s1. This is much lower than the
maximum R2 observed in Timd2-expressing cells of
116 s1, which represents an increase in R2 of over
100 s1, and four-fold greater than the predicted
increase. A possible explanation for this unexpectedly
large increase is the ferritin aggregation that we observed
in the electron micrographs (Fig. 3), which can increase
R2 for ferritin by up to five-fold (67).
An unexpected observation was that the baseline R2 in
Timd2-expressing cells was lower than in control cells,
both in vitro and in vivo (Figs. 2d,6c), although the dif-
ferences were not significant. Consistent with a lower
R2, Timd2-expressing cells also had 18% less iron than
control cells before the addition of ferritin, although
again the difference was not significant (Fig. 2e). The
reasons for this are unclear.
Incubation of Timd2-expressing cells with 75 nM
manganese-loaded apoferritin resulted in a nearly three-
fold increase in R1 after only 30 min of incubation and a
near doubling of R2, with no significant change of R2 in
the controls (Figs. 4a,c). The three-fold increase in R1
seen here in Timd2-expressing cells is similar to that
observed in hepatocytes incubated with manganese or
with manganese-loaded transferrin (68), where R1 was
increased to 1.6 s1 after 2 h incubation with 31.5 mM
Mn(III)-transferrin. The changes in R2 observed following
prolonged incubation with iron-loaded ferritin (Fig. 2)
suggest that further increases in R1 would be obtained by
extending the incubation time with manganese-loaded
apoferritin. However, these experiments were not pur-
sued in view of the evident toxicity of this contrast
agent, which was only observed in Timd2-expressing
cells and not with iron-loaded ferritin (Fig. 5). There are
few reports of other T1-based reporter genes with which
our results can be compared directly; however, in a
recent study using another reporter, which used the
same cell type and promoter, we showed increases in R1
of three- to seven-fold in vivo (16). This reporter system
based on Oatp1 and gadoxetate may be preferable to
manganese-based systems not only because of the higher
levels of contrast that have been achieved but also
because of the lower toxicity of this clinically-approved
contrast agent.
FIG. 6. Effect of ferritin injection on T2
in Timd2-expressing cells in vivo. a:
Representative H&E stained tissue sec-
tions from control and Timd2 xeno-
grafts obtained 14 days after cell
implantation. Timd2 expression was
confirmed by staining with an anti-RFP
antibody. b: T2-weighted images from a
representative mouse from (a), showing
control xenograft (left) and Timd2-
expressing xenograft (right) before, 24
and 48 h after ferritin injection. c:
Changes in T2 in Timd2-expressing tis-
sue and controls at the indicated times
after injection of ferritin. The change in
R2 was significant in Timd2-expressing
tissue but not in control tissue 24 h
after ferritin injection *P<0.05 (1-tailed
paired t-Test, n¼3). R2 values before
ferritin injection for Timd2-expressing
and control xenografts were
19.016 1.27 and 21.761.28,
respectively.
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Xenografts produced by subcutaneous injection of
Timd2-expressing cells also showed significant increases
in R2 in vivo following i.v. injection of ferritin, although
the increases were much lower than those observed in
vitro (Fig. 6). This could be due to several reasons,
including rapid clearance of ferritin from the blood (the
blood half-life in rats has been reported at being between
4 and 30 min) (69,70) and poor delivery of ferritin to the
tissue. With respect to the latter point, reporters that rely
on the use of small molecule contrast agents may have
an advantage (16,27). Contrast may be improved by
changing the timing of imaging after ferritin injection.
Although ferritin is cleared rapidly from the circulation,
we delayed imaging until 24 h to give sufficient time for
ferritin trapped nonspecifically by the enhanced perme-
ability and retention effect (71) to clear from the tissue.
However, imaging at earlier times after injection may
give better contrast. Contrast may also be improved by
giving multiple ferritin injections, because it is clear that
Timd2-expressing cells will continue to accumulate ferri-
tin over prolonged periods of time (Fig. 2). Consistent
with the literature, our data suggest that ferritin is traf-
ficked to acidic endosomal and lysosomal compartments
after uptake (Figs. 1b,c), where it has been shown to
demineralize and release free iron (61–63). As endoge-
nous ferritin expression is controlled at both the tran-
scriptional and translational level by the concentration
of free iron in the cell, this would be expected to lead to
the synthesis of new ferritin (72). This process could
explain the lag we observed between peak iron content
and the peak increase in R2 in vitro (Figs. 2d,e). Coex-
pression of Timd2 with a ferritin transgene may therefore
produce even greater changes in contrast than those
observed here, where we have relied on endogenous iron
homeostasis mechanisms to repackage the degraded ferri-
tin (4). Although manganese-loaded apoferritin would
also be expected to demineralize during uptake [manga-
nite breakdown occurs between pH 6 and pH 4 (73),
while ferrihydrite breakdown in ferritin occurs between
pH 5 and pH 2 (74)], incorporation of manganese into
native ferritin would not be expected as this does not
occur below pH 8.5 (42). A recent study investigated
coexpression of the manganese-binding protein MntR
together with the manganese importer DMT1, which has
previously been shown to function as a gene reporter
(15). However, coexpression did not lead to significant
further contrast enhancement in vivo despite promising
results in vitro (75). Expression of MntR may also pro-
vide a means of reducing the toxicity of free manganese
by binding it, however, its effect on reducing toxicity
was not investigated (75). Recent work suggests that
changes in T1r may be a more sensitive indicator of the
presence of superparamagnetic material in tissue (76),
although this has yet to be demonstrated in vivo.
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